SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sudarshan Pharma Industries informs about certificate

20 Apr 2023 Evaluate

Sudarshan Pharma Industries has informed that it attached a copy of certificate received from KFIN Technologies - Registrar & Share Transfer Agent of the Company under Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018 for the quarter ended March 31, 2023.

The above information is a part of company’s filings submitted to BSE.

Sudarshan Pharma Ind Share Price

30.21 -0.12 (-0.40%)
17-Apr-2026 12:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1678.45
Dr. Reddys Lab 1228.70
Cipla 1238.05
Zydus Lifesciences 946.55
Lupin 2311.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×